Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Xie, Chuan gao ^a   Wei, Shu mei ^a   Chen, Jia min ^a   Xu, Xuan fu ^b   Cai, Jian ting ^a   Chen, Qin yu ^a   Jia, Li tao ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE PROTEIN 100; MATRIGEL; MESSENGER RNA; PUROMYCIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL CONTACT; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MOLECULAR MECHANICS; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN FOLDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CADHERINS; CELL COMMUNICATION; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS;

EID: 84861476919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037854     Document Type: Article

References (39)

1. Li J, Wientjes MG, Au JL, (2010) Pancreatic cancer: pathobiology, treatment options, and drug delivery. AAPS J 12: 223-232.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics. CA Cancer J Clin 59: 225-249.
3. Li D, Xie K, Wolff R, Abbruzzese JL, (2004) Pancreatic cancer. Lancet 363: 1049-1057.
4. Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H, (2003) Invasion and metastasis in pancreatic cancer. Mol Cancer 2: 14.
5. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
6. Wong HH, Lemoine NR, (2009) Pancreatic cancer: molecular pathogenesis and new therapeutic Targets. Nat Rev Gastroenterol Hepatol 6: 412-422.
7. Someya A, Sata M, Takeda K, Pacheco-Rodriguez G, Ferrans VJ, et al. (2001) ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6. Proc Natl Acad Sci U S A 98: 2413-2418.
8. Chen EH, Pryce BA, Tzeng JA, Gonzalez GA, Olson EN, (2003) Control of myoblast fusion by a guanine nucleotide exchange factor, loner, and its effector ARF6. Cell 114: 751-762.
9. Dunphy JL, Moravec R, Ly K, Lasell TK, Melancon P, et al. (2006) The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins. Curr Biol 16: 315-320.
10. Hiroi T, Someya A, Thompson W, Moss J, Vaughan M, (2006) GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin. Proc Natl Acad Sci U S A 103: 10672-10677.
11. Pajcini KV, Pomerantz JH, Alkan O, Doyonnas R, Blau HM, (2008) Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. Cell Biol 180: 1005-1019.
12. Someya A, Moss J, Nagaoka I, (2006) Involvement of a guanine nucleotide-exchange protein, ARF-GEP100/BRAG2a, in the apoptotic cell death of monocytic phagocytes. J Leukoc Biol 80: 915-921.
13. Dunphy JL, Ye K, Casanova JE, (2007) Nuclear functions of the Arf guanine nucleotide exchange factor BRAG2. Traffic 8: 661-672.
14. Someya A, Moss J, Nagaoka I, (2010) The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process. J Biol Chem 285 (40): 30698-30707.
15. Hashimoto A, Hashimoto S, Ando R, Noda K, Ogawa E, et al. (2011) GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS One 6: e23359.
16. Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, et al. (2008) GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 10: 85-92.
17. Menju T, Hashimoto S, Hashimoto A, Otsuka Y, Handa H, et al. (2011) Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma. PLoS One 6: e25301.
18. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E, (2008) Epithelial-mesenchymal transition. Cancer Res 68: 9574-9577.
19. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G, (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
20. Karayiannakis AJ, Syrigos KN, Chatzigianni E, Papanikolaou S, Alexiou D, et al. (1998) Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res 18: 4177-4180.
21. Takao S, Che X, Fukudome T, Natsugoe S, Ozawa M, et al. (2000) Down-regulation of E-cadherin by antisense oligonucleotide enhances basement membrane invasion of pancreatic carcinoma cells. Hum Cell 13: 15-21.
22. Hong SM, Li A, Olino K, Wolfgang CL, Herman JM, et al. (2011) Loss of E-cadherin expression and outcome among patientswith resectable pancreatic adenocarcinomas. Mod Pathol 24: 1237-1247.
23. Jamieson NB, Carter CR, McKay CJ, Oien KA, (2011) Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Clin Cancer Res 17: 3316-3331.
24. Shishido T, Yasoshima T, Denno R, Mukaiya M, Sato N, et al. (1998) Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin. Jpn J Cancer Res 89: 963-969.
25. Jimenez RE, Hartwig W, Antoniu BA, Compton CC, Warshaw AL, et al. (2000) Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann Surg 231: 644-654.
26. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, et al. (2009) Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69: 5820-5828.
27. Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, et al. (2010) Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39: 425-435.
28. Casanova JE, (2007) Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffic 8: 1476-1485.
29. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, et al. (2004) Requirement for Arf6 in breast cancer invasive activities. ProcNatlAcadSci U S A 101: 6647-6652.
30. Baranwal S, Alahari SK, (2009) Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 384: 6-11.
31. Delva E, Kowalczyk AP, (2009) Regulation of cadherin trafficking. Traffic 10: 259-267.
32. Nieto MA, Sargent MG, Wilkinson DG, Cooke J, (1994) Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264: 835-839.
33. Nieto MA, (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166.
34. Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial tomesenchymal transitions: a comparison with Snail and E47repressors. J Cell Sci 116: 499-511.
35. Alves CC, Carneiro F, Hoefler H, Becker KF, (2009) Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci 14: 3035-3050.
36. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, et al. (2007) Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776.
37. Watanabe T, Sato K, Kaibuchi K, (2009) Cadherin-mediated intercellular adhesion and signaling cascades involving small GTPases. Cold Spring Harb Perspect Biol 1: a003020.
38. Hiroi T, (2009) Regulation of epithelial junctions by proteins of the ADP-ribosylation factor family. Front Biosci 14: 717-730.
39. Palacios F, Price L, Schweitzer J, Collard JG, D'Souza-Schorey C, (2001) An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J 20: 4973-4986.